Pricing

Umoja Biopharma

3 followers

‌

Umoja is developing a new approach to cancer therapy that retools a patient’s immune system in vivo, enhancing the body’s natural capacity to fight cancer.

Industries

Pharmaceutical

Headquarters

Seattle, United States

Employees

11-50

Links

Org chart

Andy Scharenberg

Co-founder and CEO

Andy Scharenberg

Collapse

Ryan Crisman

Co-founder and CTO

Andrea Rosa

Director, Financial Planning & Analysis

Principal Scientist

Principal Scientist

Head Of Quality

Chief Of Staff & Head Of Administration

Matthew Harms

Executive Director, Early Commercial & Business Insights

David Fontana

COO And CBO

Christian R. Schubert

Observer | Board Of Directors

Board & advisors

Andy Scharenberg

Co-Founder & CEO

Luke Evnin

Director

Phil Low

Co-founder, Umoja; Director

Director

Director

Director

Co-founder, Umoja; Advisor

Rimas Orentas

Advisor

Hans-Peter Kiem

Advisor

Franklin M. Berger

Advisor

Teams

+15

Directors and Senior Managers

18 members

Research and Development

9 members

Facilities and Operations

9 members

Quality Assurance and Control Team

6 members

Leadership Team

4 members

Offices

Similar companies

Charlie Health

6 followers

Madrigal Pharmaceuticals

2 followers

Rimsys

2 followers

Bristol-Myers Squibb

207 followers

Walgreens Boots Alliance

112 followers

Lundbeck

38 followers

Syneos Health

23 followers

Apellis Pharmaceuticals

9 followers

Octapharma Plasma

7 followers

DispatchHealth

6 followers

Clario

4 followers

Explore companies